Repros Therapeutics reports Q1 EPS (37c), consensus (35c)
moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring next, click here to view […]
RPRX
REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition
moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring next, click here to view […]
Repros Therapeutics Inc.(R) Reports First Quarter 2014 Financial Results
[GlobeNewswire] – THE WOODLANDS, Texas — Repros Therapeutics Inc.(R) today announced financial results for the first quarter ended March 31, 2014. moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring next, click here to view […]
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure
moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring next, click here to view […]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repros Therapeutics, Inc. – RPRX
[PR Newswire] – NEW YORK, May 5, 2014 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Repros Therapeutics, Inc. (Repros or the Company) (RPRX) (CUSIP:76028H209). Investors are advised to contact Robert S. Willoughby at rsw moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring […]
4:04 pm Repros Therapeutics: FDA recommends sperm endpoints as key parameters for assessment of Androxal versus approved topical gel
moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring next, click here to view […]
Repros Completes Enrollment for Androxal Study
moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring next, click here to view […]
Data on Repros’ Androxal
moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring next, click here to view […]
Repros Reports Both Primary Endpoints Successfully Met in First Pivotal Study of Androxal®
[at noodls] – Contact: Repros Therapeutics Inc. … This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring next, click here to view […]
FDA Grants Repros An End of Phase 2 Meeting in Late May to Discuss Proellex®-V Phase 3 Study Design
[at noodls] – Contact: Repros Therapeutics Inc….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on RPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Repros is hiring next, click here to view […]
